Original Research
Published on 29 Sep 2023
Teriflunomide and Epstein–Barr virus in a Spanish multiple sclerosis cohort: in vivo antiviral activity and clinical response
in Multiple Sclerosis and Neuroimmunology
- 3,910 views
- 3 citations
Original Research
Published on 29 Sep 2023
in Multiple Sclerosis and Neuroimmunology
Original Research
Published on 29 Sep 2023
in Multiple Sclerosis and Neuroimmunology
Original Research
Published on 20 Sep 2023
in Multiple Sclerosis and Neuroimmunology
Brief Research Report
Published on 18 Sep 2023
in Multiple Sclerosis and Neuroimmunology
Original Research
Published on 13 Sep 2023
in Multiple Sclerosis and Neuroimmunology
Review
Published on 12 Sep 2023
in Multiple Sclerosis and Neuroimmunology
Original Research
Published on 06 Sep 2023
in Multiple Sclerosis and Neuroimmunology
Original Research
Published on 06 Sep 2023
in Multiple Sclerosis and Neuroimmunology
Original Research
Published on 05 Sep 2023
in Multiple Sclerosis and Neuroimmunology
Original Research
Published on 30 Aug 2023
in Multiple Sclerosis and Neuroimmunology
Original Research
Published on 29 Aug 2023
in Multiple Sclerosis and Neuroimmunology
Original Research
Published on 29 Aug 2023
in Multiple Sclerosis and Neuroimmunology
Case Report
Published on 28 Aug 2023
in Multiple Sclerosis and Neuroimmunology
Review
Published on 24 Aug 2023
in Multiple Sclerosis and Neuroimmunology
Original Research
Published on 22 Aug 2023
in Multiple Sclerosis and Neuroimmunology
Editorial
Published on 18 Aug 2023
in Multiple Sclerosis and Neuroimmunology